STOCK TITAN

CRWV (NASDAQ: CRWV) insiders detail planned stock sale and 10b5-1 trades

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV filed a notice of proposed sale of common stock. The filing lists 12,500 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services at an aggregate value of $915,125.00, with a proposed sale date of July 20, 2026 on NASDAQ.

The filing also details extensive Rule 10b5-1 trading plan sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities. Individual transactions include, for example, a 200,000-share sale for $21,806,780.00 on April 27, 2026 and recurring 144,000-share sales on multiple June and July 2026 dates.

Positive

  • None.

Negative

  • None.
Shares to be sold 12,500 shares Common stock proposed for sale through Morgan Stanley Smith Barney LLC
Proposed aggregate sale price $915,125.00 Aggregate value for 12,500 common shares to be sold on NASDAQ
Proposed sale date 07/20/2026 Date tied to the 12,500-share common stock sale
Large 10b5-1 sale 200,000 shares Brannin McBee sale of common stock on 04/27/2026
Proceeds from 200,000-share sale $21,806,780.00 Value of Brannin McBee’s 10b5-1 sale on 04/27/2026
Recurring 10b5-1 sale size 144,000 shares Common stock sold by Brannin McBee on multiple June–July 2026 dates
Rule 10b5-1 regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 02/25/2019 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
irrevocable trust financial
"CANIS MAJOR 2024 IRREVOCABLE TR LLC 290 W Mt. Pleasant Ave."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
GRAT financial
"CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does CRWV’s latest Form 144 filing disclose?

The filing discloses a proposed sale of 12,500 CRWV common shares through Morgan Stanley Smith Barney LLC for an aggregate value of $915,125.00, along with extensive recent Rule 10b5-1 plan sales by insiders and related trusts over the prior three months.

How many CRWV shares are proposed to be sold and at what value?

The notice covers a proposed sale of 12,500 CRWV common shares with a stated aggregate value of $915,125.00. These shares are to be sold on NASDAQ, with Morgan Stanley Smith Barney LLC Executive Financial Services acting as the broker for the transaction.

When is the proposed sale date for the 12,500 CRWV shares?

The proposed sale date for the 12,500 CRWV common shares is July 20, 2026. This date is associated with the transaction handled by Morgan Stanley Smith Barney LLC Executive Financial Services, as indicated in the Form 144 disclosure.

Which broker is handling the proposed CRWV common stock sale?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker handling the proposed sale of 12,500 CRWV common shares. The transaction is associated with its office at 1 New York Plaza, 8th Floor, New York, NY 10004 and NASDAQ trading.

What recent Rule 10b5-1 sales of CRWV stock are reported?

The disclosure lists multiple Rule 10b5-1 sales, including Brannin McBee’s 200,000-share sale for $21,806,780.00 on April 27, 2026 and recurring 144,000-share sales on June and July 2026 dates by Brannin McBee and related entities.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature